Improvement in thyroid ultrasound report quality with radiologists' adherence to 2015 ATA or 2017 TIRADS: a population study.

thyroid thyroid imaging ultrasound

Journal

European thyroid journal
ISSN: 2235-0640
Titre abrégé: Eur Thyroid J
Pays: England
ID NLM: 101604579

Informations de publication

Date de publication:
14 Jun 2022
Historique:
received: 02 05 2022
accepted: 05 05 2022
pubmed: 7 5 2022
medline: 7 5 2022
entrez: 6 5 2022
Statut: epublish

Résumé

There has been slow adoption of thyroid ultrasound guidelines with adherence rates as low as 30% and no population-based studies investigating adherence to guideline-based malignancy risk assessment. We therefore evaluated the impact of adherence to the 2015 ATA guidelines or 2017 ACR-TIRADS guidelines on the quality of thyroid ultrasound reports in our healthcare region. We reviewed 899 thyroid ultrasound reports of patients who received fine-needle aspiration biopsy and were diagnosed with Bethesda III or IV nodules or thyroid cancer. Ultrasounds were reported by radiology group 1, group 2, or other groups, and were divided into pre-2018 (before guideline adherence) or 2018 onwards. Reports were given a utility score (0-6) based on how many relevant nodule characteristics were included. Group 1 had a pre-2018 utility score of 3.62 and 39.4% classification reporting rate, improving to 5.77 and 97.0% among 2018-onwards reports. Group 2 had a pre-2018 score of 2.8 and reporting rate of 11.5%, improving to 5.58 and 93.3%. Other radiology groups had a pre-2018 score of 2.49 and reporting rate of 32.2%, improving to 3.28 and 61.8%. Groups 1 and 2 had significantly higher utility scores and reporting rates in their 2018-onward reports when compared to other groups' 2018-onward reports, pre-2018 group 1 reports, and pre-2018 group 2 reports. Dedicated adherence to published thyroid ultrasound reporting guidelines can lead to improvements in report quality. This will reduce diagnostic ambiguity and improve clinician's decision-making, leading to overall reductions in unnecessary FNA biopsy and diagnostic surgery.

Identifiants

pubmed: 35521979
doi: 10.1530/ETJ-22-0035
pii: ETJ-22-0035
pmc: PMC9254273
doi:
pii:

Types de publication

Journal Article

Langues

eng

Références

Can Assoc Radiol J. 2021 May;72(2):234-241
pubmed: 32090615
Endocrine. 2018 Aug;61(2):303-307
pubmed: 29802606
Endocrine. 2017 Aug;57(2):256-261
pubmed: 27804016
AJR Am J Roentgenol. 2020 Apr;214(4):900-906
pubmed: 32069084
Endocr Pract. 2016 May;22(5):622-39
pubmed: 27167915
BMC Endocr Disord. 2019 Oct 29;19(1):112
pubmed: 31664992
Endocrinol Metab Clin North Am. 2001 Jun;30(2):339-60, viii-ix
pubmed: 11444166
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Am Coll Radiol. 2017 May;14(5):587-595
pubmed: 28372962
Head Neck. 2018 Apr;40(4):722-727
pubmed: 29247582
Rev Endocr Metab Disord. 2021 Jun;22(2):453-460
pubmed: 32959174
Thyroid. 2021 Oct;31(10):1542-1548
pubmed: 34314256
Acad Radiol. 2018 Jul;25(7):915-924
pubmed: 29398434
J Am Coll Radiol. 2018 May;15(5):743-748
pubmed: 29503150
Endocr Pract. 2019 Sep;25(9):908-917
pubmed: 31170369

Auteurs

X Y Hu (XY)

Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

J Wu (J)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

P Seal (P)

EFW Radiology, Calgary, Alberta, Canada.

S A Ghaznavi (SA)

Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

C Symonds (C)

Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

S Kinnear (S)

Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

R Paschke (R)

Department of Medicine, Section of Endocrinology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Classifications MeSH